top
Search terms
Results 1 - 8 of 8 - ordered by :
Ehjournal

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from ...

European Heart Journal, Stefanini, Giulio G., Byrne, Robert A., Serruys, Patrick W., de Waha, Antoinette, Meier, Bernhard, Massberg, Steffen, Jüni, Peter, Schömig, Albert, Windecker, Stephan, ...

Date : 01/05/2012 Item size : 275670 bytes
Ehjournal

Methods This multicentre, randomized, double-blind, placebo-controlled trial tested the hypothesis that in patients undergoing DES implantation, 6 months of clopidogrel is non-inferior to 12 months ...

European Heart Journal, Schulz-Schüpke, Stefanie, Byrne, Robert A., ten Berg, Jurrien M., Neumann, Franz-Josef, Han, Yaling, Adriaenssens, Tom, Tölg, Ralph, Seyfarth, Melchior, Maeng, Michael, ...

Date : 21/05/2015 Item size : 392042 bytes
Ehjournal

Methods and results The Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 study is an investigator-initiated, randomized, open-label, multicentre trial, designed to test the hypothesis that in ...

European Heart Journal, Schulz, Stefanie, Richardt, Gert, Laugwitz, Karl-Ludwig, Morath, Tanja, Neudecker, Julia, Hoppmann, Petra, Mehran, Roxana, Gershlick, Anthony H., Tölg, Ralph, Anette ...

Date : 07/09/2014
Ehjournal

Yet, a reduction in death and myocardial infarction could not be shown with these devices; instead there were concerns about an excess of late thrombotic events compared with bare metal stents ...

European Heart Journal, Schulz, Stefanie, Kastrati, Adnan

Date : 21/03/2013 Item size : 185818 bytes
Ehjournal

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from ...

European Heart Journal, Stefanini, Giulio G., Byrne, Robert A., Serruys, Patrick W., de Waha, Antoinette, Meier, Bernhard, Massberg, Steffen, Jüni, Peter, Schömig, Albert, Windecker, Stephan, ...

Date : 01/05/2012 Item size : 282810 bytes
Ehjournal

Abstract Aims In ISAR-REACT 3, 30-day outcomes in 4570 biomarker negative patients undergoing percutaneous coronary intervention (PCI) 2 h after pre-treatment with 600 mg of clopidogrel revealed less ...

European Heart Journal, Schulz, Stefanie, Mehilli, Julinda, Ndrepepa, Gjin, Neumann, Franz-Josef, Birkmeier, Katrin A., Kufner, Sebastian, Richardt, Gert, Berger, Peter B., Schömig, Albert, ...

Date : 01/03/2010 Item size : 245580 bytes
Ehjournal

Methods and results The Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 study is an investigator-initiated, randomized, open-label, multicentre trial, designed to test the hypothesis that in ...

European Heart Journal, Schulz, Stefanie, Richardt, Gert, Laugwitz, Karl-Ludwig, Morath, Tanja, Neudecker, Julia, Hoppmann, Petra, Mehran, Roxana, Gershlick, Anthony H., Tölg, Ralph, Anette ...

Date : 07/09/2014
Ehjournal

Methods This multicentre, randomized, double-blind, placebo-controlled trial tested the hypothesis that in patients undergoing DES implantation, 6 months of clopidogrel is non-inferior to 12 months ...

European Heart Journal, Schulz-Schüpke, Stefanie, Byrne, Robert A., ten Berg, Jurrien M., Neumann, Franz-Josef, Han, Yaling, Adriaenssens, Tom, Tölg, Ralph, Seyfarth, Melchior, Maeng, Michael, ...

Date : 21/05/2015 Item size : 457603 bytes